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Abstract
Background: Ankle fracture is a common injury with a strong evidence base focused on effectiveness of
treatments. However, there are no reporting guidelines on distal tibia and ankle fractures. This has led to
heterogeneity in outcome reporting and consequently, restricted the contribution of evidence syntheses. Over the
past decade, core outcome sets have been developed to address this issue and are available for several common
fractures, including those of the hip, distal radius, and open tibial fractures. This protocol describes the process to
co-produce—with patient partners and other key stakeholders—a multi-stakeholder derived Core Outcome Set for
distal Tibia and Ankle fractures (COSTA). The scope of COSTA will be for clinical trials.
Methods: The study will have five-stages which will include the following: (i) systematic reviews of existing
qualitative studies and outcome reporting in randomised controlled trial studies to inform a developing list of
potential outcome domains; (ii) qualitative interviews (including secondary data) and focus groups with patients
and healthcare professionals to explore the impact of ankle fracture and the outcomes that really matter; (iii)
generation of meaningful outcome statements with the study team, international advisory group and patient
partners; (iv) a multi-round, international e-Delphi study to achieve consensus on the core domain set; and (v) an
evidence-based consensus on a core measurement set will be achieved through a structured group consensus
meeting, recommending best assessment approaches for each of the domains in the core domain set.
Discussion: Development of COSTA will provide internationally endorsed outcome assessment guidance for clinical
trials for distal tibia and ankle fractures. This will enhance comparative reviews of interventions, potentially reducing
reporting bias and research waste.
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Background
Fractures are a common problem with incidence rates in
the UK reported to be 73.3 per 10,000 in adults aged
18–49 years, increasing to 116.3 per 10,000 in adults
aged 50+ years [1]. Recent evidence indicates that 14%
of hospital fracture admissions in England were for distal
tibia and ankle fractures [2]. Lower-limb fractures are as-
sociated with both short and long-term disability and
pain [3, 4]. Evidence suggests that recovery can be slow
[5] with substantial variation in how quickly or success-
fully patients return to their preinjury lives [5, 6]; many
patients report experiencing prolonged disability [7].
However, evidence exploring the recovery and impact of
such injuries is limited. Growing evidence suggests that
an ankle fracture can affect physical, social and psycho-
logical functioning with indications of fatigue, depres-
sion, anxiety, and disturbed sleep [8]. However, due to
inconsistent outcome selection and reporting, it is diffi-
cult to collate and synthesise evidence to scrutinise these
findings [9–11].
Evidence syntheses are essential for collating and de-
termining the strength of evidence for interventions,
informing, and advancing healthcare provision. However,
such evidence syntheses (e.g. meta-analysis) rely on
homogeneity in outcome selection and reporting to draw
evidence together [12]. The need and benefits of uni-
formity in outcome selection and reporting have been
well described [13–16], including the following: (i) in-
creased relevance of outcomes included in trials (to
healthcare services users and professionals); (ii) en-
hanced homogeneity in outcome reporting between
studies, thus strengthening meta-analyses through wider
inclusion of research studies; (iii) reducing outcome
reporting bias; and (iv) reducing research waste [16].
Significant progress has been made towards developing
reporting guidance across a range of fractures, with core
outcome sets in development or available for hip [17],
distal radius [18], open lower limb [19], and shoulder
disorders (including proximal humeral fractures) [20].
However, there is currently no guidance for distal tibia
and ankle fractures. In a 2012 Cochrane review of re-
habilitation for adults with ankle fractures, researchers
highlighted that clinical and statistical heterogeneity be-
tween studies was a substantive challenge when con-
ducting meta-analyses [9]. This issue has persisted with
subsequent reviews examining return to sport in adults
[10] and managing low risk ankle fractures in children
[11] also identifying the challenge of heterogeneity in
outcome selection and reporting and its detrimental ef-
fect on conducting evidence synthesis. The need for a
core outcome set for distal tibia and ankle fractures is
clear and has been recently recommended to increase
outcome reporting homogeneity in ankle fracture re-
search [21]. Currently, there is work ongoing to develop
a core outcome set for ankle fractures specifically for
children [22] but no guidance for adults.
A Core Outcome Set (COS) is an agreed minimum
number of outcomes that should be measured and re-
ported in all trials for a specific clinical area [16]. Two
key development stages are described [23–25].
1. Clarifying the outcome domains that matter to key
stakeholders and should be minimally assessed in
future clinical trials (Core Domain Set; CDS).
2. Confirming the assessment method(s) for each
outcome domain (Core Measurement Set; CMS).
Current best practice guidance [24, 25] describes a
mixed-methods approach, integrating evidence from lit-
erature reviews, patient interviews, and active engage-
ment with key stakeholders to reach consensus.
Additionally, establishing advisory groups with key
stakeholders is recommended and widely described
[26–29], contributing to improved COS uptake [16].
Similarly, public involvement groups can enhance the
full research process, including identification of unique
outcomes for incorporation within the COS [16, 30].
This protocol describes the process for co-producing a
multi-stakeholder derived Core Outcome Set for distal
Tibia and Ankle fractures (COSTA).
Methods
A five-stage approach will be adopted (Fig. 1) [24, 25].
The first three stages include preparatory activities to in-
form the generation of potential outcome domains for
consideration in the e-Delphi study: systematic reviews of
existing qualitative studies and outcome reporting in ran-
domised controlled trial studies (stage 1) qualitative inter-
views (including secondary data) and focus groups with
both patients and healthcare professionals to explore the
impact of ankle fracture and the outcomes that really mat-
ter (stage 2) and generating meaningful outcome state-
ments with the research team, international advisory
group, and patient partners (stage 3). A multi-round,
international e-Delphi study will seek to achieve consen-
sus on the Core Domain Set (CDS) for the distal tibia and
ankle fracture core outcome set (COSTA) (Stage 4) and,
finally, a consensus meeting to agree a Core Measurement
Set (CMS) and recommend the COS for distal Tibia and
Ankle fracture (COSTA) (Stage 5). The COSTA project is
registered with the Core Outcome Measures in Effective-
ness Trials (COMET) initiative (http://www.comet-
initiative.org/Studies/Details/1488).
Aim
A protocol for the development of a core outcome set
for distal tibia and ankle fractures (COSTA) for use in
clinical trials.
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Objectives
1. To develop a long list of important outcome
domains, incorporating the perspectives of multiple
stakeholders (researchers, patients, healthcare
professionals) (stages 1 and 2).
2. To generate meaningful statements for identified
outcome domains (stage 3).
3. To achieve consensus on the core domain set for
COSTA (stage 4).
4. To achieve consensus on a core measurement set
for COSTA (stage 5).
Design
Three groups will be actively involved in the COSTA
project:
1. Core research team: consisting of methodologists,
clinicians, and a patient partner, will meet monthly
to discuss project design issues and progress.
2. International advisory group: consisting of
methodologists (core outcome set, health
measurement), clinicians, and researchers with
experience in distal tibia and ankle fractures and
clinical trials, with representation from funding
Fig. 1 Flow diagram illustrating the process of developing COSTA
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bodies and journals. This group will meet every 6
months to discuss COSTA progress.
3. Patient and public involvement (PPI) group: will be
established to work collaboratively with the core
research team in delivering the project. Their
involvement will ensure that COSTA is relevant
and acceptable to distal tibia and ankle patients.
Regular meetings and email communication will be
initiated to achieve and support active engagement.
Scope
The purpose of COSTA is to provide outcome selection
and reporting guidance for:
Research or practice settings: For adoption in clinical
trials.
Health condition: Fracture of the distal tibia and ankle.
Population: Adults (aged 18 years or older with closed
growth plates) who have experienced a distal tibia (tibia,
distal end segment type 43) and ankle fracture (malleolar
segment type 44) as defined by the AO/OTA classifica-
tion [31].
Intervention: Any surgical or non-surgical intervention
including physical rehabilitation.
Incorporating patient and public involvement (PPI) into
COS development
A COSTA-specific PPI group will be established from
existing PPI networks. Members will include individuals
who have experienced distal tibia and ankle fractures or
been involved in caring for someone following an ankle
fracture. Evidence suggests that failure to incorporate
patients can lead to important outcomes being over-
looked [32]. Moreover, active PPI can enrich the re-
search process through improved outcome identification
[33, 34] and greater participant retention in key stages of
COS development, e.g. e-Delphi surveys [35]. Active col-
laboration with PPI members as patient research part-
ners in the research process will ensure that outcomes
that are important and relevant to patients are reflected
in the COS [30].
A ‘co-production’ approach to COS development will
be adopted [36], underpinned by the COMET People
and Patient Participation, Involvement and Engagement
(PoPPIE) guidance [37] and the six UK standards for
public involvement [38]. Our patient research partners
will have roles that are comparable to the research team
but without the day-to-day responsibilities of running
the project. They will be supported to contribute
throughout the study, including shaping ethics applica-
tions, study materials (e.g. interview schedules), data
analysis and interpretation, reviewing, modifying, and
generating meaningful statements for the outcomes list
and ratifying the core domain set. Their involvement will
be reported using the Guidance for Reporting
Involvement of Patients and the Public (GRIPP2) short-
form checklist [39].
Stage one: reviews of outcome reporting in clinical trials
and of patient experiences of recovery
We will conduct two systematic literature reviews to
identify reported outcomes in (1) intervention rando-
mised control trial (RCT) studies and (2) qualitative
studies exploring the patient experience and recovery
following an ankle fracture. Both reviews will use the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses [40] guidance to support transparency in
reporting.
Review of trial outcome reporting
This review will support the development of an out-
comes list that incorporates what is important to re-
searchers. Searches will be conducted across five
databases (from 2000 to 2021): Medline (OVID),
EMBASE (OVID), PsycINFO (OVID), CINAHL, and
AMED. Additionally, three trial registries (ISRCTN,
ICTRP, and ClinicalTrials.gov) and the Cochrane Cen-
tral Register of Controlled Trials (CENTRAL) will be
searched. One experienced reviewer (NP) will screen ti-
tles and abstracts and determine whether they meet eli-
gibility criteria (Table 1); a 10% subset will be double
assessed by another experienced reviewer (KH) to check
for accuracy and consistency. Any disagreements will be
resolved through discussion and if necessary, a third re-
viewer (ET) will be consulted. NP and KH (10% subset)
will extract information which will include the study ref-
erence, design, population and sample size, interventions
studied, and outcomes reported (e.g. health, clinical, so-
cial, economic) and measurement approaches (e.g. pa-
tient or clinician reported outcome). Additionally, the
review will also examine clarity of reporting and extract
information on whether used measures are reproducible,
include appropriate references, and if they have been
modified for the study. Outcomes will be grouped using
the World Health Organisation (WHO) International
Classification of Functioning, Disability and Health
model (ICF) [41].
Review of qualitative reports of patient experiences of
recovery following ankle fracture
This review aims to examine and synthesise evidence
from existing qualitative studies exploring patient ex-
perience of injury and recovery from distal tibia or ankle
fracture, ensuring relevant outcomes to patients are
reflected in the developing outcomes list. Additionally,
this review will contribute to our wider understanding of
ankle fracture experience and recovery.
Searches will be conducted across five databases (from
2000 to 2020): Medline (OVID), EMBASE (OVID),
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PsycINFO (OVID), CINAHL, and AMED. One experi-
enced reviewer (NP) will screen titles and abstract to de-
termine eligibility with a 10% subset double-assessed by
a second experienced reviewer (ET) to check for accur-
ate and consistent application of the eligibility criteria
(Table 1). Disagreements will be resolved, where neces-
sary, through discussion or in consultation with a third
reviewer (KH).
Data will be extracted and analysed by NP and ET and
managed using NVivo software. Data will be analysed
using thematic synthesis [42] to elucidate higher-order
analytical themes; this will supplement the extraction of
important outcomes. Outcomes will be grouped using
the WHO ICF framework [41] and incorporated into the
developing outcomes list.
Stage two: Understanding experiences and ‘what matters’
to patients and healthcare professionals
Part A: Interviews with patients
We will conduct semi-structured interviews with a pur-
posive sample of up to 30 individuals who have experi-
enced distal tibia and ankle fractures. This sample size
will allow for a range of views to be expressed across in-
juries (distal tibia, ankle) and age groups (younger and
older adults) to be captured. Interviews will be guided by
an interview schedule co-produced between the research
team and patient partners (Table 2) and are anticipated
to last up to one 1 h. All interviews will be audio-
recorded and transcribed verbatim. Notes will be taken
during and after interview to support analysis, interpret-
ation, and reflexivity.
Sampling criteria will include their treatment strategy
(operative or non-operative), type of injury, time since
injury, and geographic location. Recognising that there is
a bimodal incidence of ankle fractures in adults by age,
with younger patients often experiencing high energy
fractures and older patients more often experiencing low
energy fractures [43], sampling will ensure a range of
ages are included to ensure a breadth of perspectives are
captured in interviews. Participants will be aged 18 years
or older, will have experienced distal tibia and ankle
fractures within the last 9 months, and be able to com-
municate (written and verbally) in English. Participants
will be identified through clinical lists maintained by
their local hospital trauma department. Given the evolv-
ing situation with COVID-19, interviews will either be
conducted face-to-face, virtually (via webcam) or by tele-
phone, depending on safety guidance. Patients will be
unknown to the researcher prior to interview.
The interviews will draw on interpretative phenom-
enological analysis (IPA) as a methodological framework
[26], an analysis process developed specifically to provide
Table 1 Eligibility criteria for inclusion in reviews
Inclusion criteria Exclusion criteria
Trial outcome
reporting
Randomised clinical trials examining non-pharmacological interven-
tions for adults with an ankle fracture
Article reports multiple lower limb fractures that include
the ankle (e.g. foot, tibia), or paediatric patients
Available in English, full text and published in a peer-reviewed
journal
Trial focuses on screening or diagnostic methods
Study is an animal or cadaver study
Publication is a conference proceeding, editorial or




Conducted with people who have experienced distal tibia or ankle
fracture
Conducted with healthcare professionals
Have used qualitative research methods to explore experience of
injury and recovery from distal tibia or ankle fracture
Studies using quantitative methods only
Mixed method studies with a separately analysed and reported
qualitative component
Publication is a conference proceeding, editorial or
available as an abstract only
Article available in English, full-text and published in a peer-
reviewed journal
Table 2 Patient co-produced interview questions and prompts
Interview questions and prompts
The two key questions will be:
What has it been like for you since you injured your ankle? Prompts: Tell
me more about that, how did you feel, what did you think?
What is important to you about your recovery from the fracture?
Prompts: What is most important to you? What are you hoping for?
Other questions may be useful to guide the interview such as:
Could you tell me about how you fractured your ankle?
How did you/ are you managing with the injury?
- Work
- Personal and social life
- Feelings and mood
What was most difficult time for you?
How are you feeling/ what are you thinking/ about your recovery?
How has your injury impacted on you?
Are there things you could do before, but you can’t now?
Did/ do you have any worries or concerns about your injury or
recovery?
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methodological direction for research that focuses on
understanding the lived experience of others [26]. The
analysis consists of two elements:
1. A thematic analysis [44], drawing on the impact
triad of severity, importance, and self-management
[45], will be conducted to develop a framework of
meaningful patient outcomes. These outcomes will
be mapped to the ICF framework [41] and contrib-
ute to the developing outcomes list (from the sys-
tematic reviews).
2. A separate IPA will be conducted on a
homogeneous subset of up to 10 interviews. This
will make a separate contribution to the evidence
base by developing our understanding of the lived
experiences of patients with distal tibia and ankle
fractures and their recovery. The analysis will be
inductive and continuous, following the process
described by Smith, Flowers, and Larkin [46].
Interviews will be conducted and coded by NP, ET,
and KH, none of whom are involved in routine patient
care. All researchers are experienced in conducting in-
terviews and have used IPA and thematic analysis.
NVivo software will be used to manage the data. NP is
experienced in mixed methods, a male Research Fellow
with a PhD in Health Sciences, and a background in
Psychology and Cognitive Neuroscience. ET is an experi-
enced, qualitative, female researcher with a PhD in
Health Sciences and a focus on traumatic orthopaedic
injuries. KH is a female with a DPhil in Health Sciences
and Clinical Evaluation; she is a mixed methods re-
searcher with experience across a range of patient
populations.
Rigour will be guided by the principles proposed by
Yardley [47]. These criteria reflect sensitivity to context,
commitment and rigour, transparency and coherence,
and impact and importance. Sensitivity to context will
be demonstrated through consideration of relevant lit-
erature, theoretical understanding and understanding
the perspective of participants. Commitment and rigour
will be demonstrated through in-depth engagement with
the topic, thorough data collection and the depth of ana-
lysis. Transparency and coherence will be demonstrated
through the detailed accounts from participants, reflexiv-
ity, and the production of a clear audit trail that captures
key quotes that inform theme derivation. Finally, impact
and importance will be demonstrated through develop-
ment of our theoretical and practical understanding of
fracture experience and recovery.
Secondary data analysis of existing interview data
A secondary analysis of existing interview data, garnered
from a qualitative sub study of the “Ankle Fracture
Treatment: Enhancing Recovery” (AFTER) [48] study,
will be conducted (ET). The main study included 60
adults, aged 50 years and above, who had sustained an
ankle fracture and consented to take part in a study of
progressive functional exercise versus best practice ad-
vice. The qualitative study explored the lived experience
and 6-month recovery in twenty patients. Important out-
comes will be extracted from this data as part of the on-
going phenomenological analysis. The AFTER study is
wholly independent of the COSTA initiative and will be
reported separately by the respective authors (DK, ET).
Part B: Focus groups or interviews with healthcare
professionals
Given the evolving circumstances and current pressures
on healthcare professionals regarding COVID-19, the
conducting of focus groups may not be feasible at the
point of study commencement. Consequently, alterna-
tive arrangements have been developed which would use
interviewing as per the approach taken in Part A with
patients. Here, we will explore the experiences of profes-
sionals working with or treating ankle fracture patients
before reviewing and potentially adding to the outcomes
list derived from the systematic reviews. Whilst the
benefit of group discussion and sharing experiences may
be lost using an interview approach, they will ensure that
the healthcare professional perspective is incorporated
into the developing outcomes list.
Should it be possible to host focus groups, up to four
will be held and co-facilitated by members of the re-
search team with experience in conducting focus
groups. Previous experience suggests that focus group
attendance tends to be difficult to predict. Current
guidance recommends between 5 and 12 participants
are required for an effective focus group discussion.
Therefore, this study will seek to recruit at the upper
end (n = 12) of this guidance to accommodate likely at-
trition [49–51]. Professionals will be purposively sam-
pled based on their professional role (e.g. clinicians,
occupational therapists, physiotherapists, nurses). It is
anticipated that the focus group will take up to 1 h, in-
cluding a short 10-min comfort break. To participate,
healthcare professionals will have experience working
within a trauma setting, including with patients who
have experienced relevant fractures to the study (distal
tibia or ankle). Professionals will be identified and
approached by site principal investigators, snowballing,
and personal contacts.
Data will be analysed using thematic analysis [44] to
identify key outcomes and themes as per the process de-
scribed in Part A interviews. The findings of the focus
groups/ interviews will support identification of distal
tibia and ankle fracture outcomes that are considered
important to healthcare professionals. The process of
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ensuring rigour and transparency will again follow the
principles proposed by Yardley [47].
Stage three: Generating meaningful outcome statements
The long list of outcomes generated in stages 1 and 2 will
be discussed with members of the core, international advis-
ory, and PPI groups. Working collaboratively with all mem-
bers, outcome statements will be generated for each
outcome domain and mapped to the World Health Organ-
isation (WHO) International Classification of Functioning,
Disability and Health model (ICF) [41]—a structured and
widely recognised outcomes framework that will support
greater transparency and consistency in the language used
to describe potential outcome domains [52].
A face-to-face (or digitally hosted) meeting will be
scheduled across one full day (if possible) or alternatively,
two half-day sessions, and materials sent to participants in
advance of the meeting for their consideration. These ma-
terials will include research findings (from reviews and
qualitative data) and a questionnaire for participants to
complete and return in advance of the meeting, listing all
outcomes with potential definitions. When completing the
questionnaire, participants will consider outcome do-
mains, definitions, and whether any important outcome
domains are missing. The meeting will be structured using
a modified nominal group technique to facilitate group
discussions. This will consist of three stages:
1. Reviewing the research findings: work completed will
be discussed; the results of the pre-meeting survey
will be discussed.
2. Refining outcome priorities: the list of outcome
domains will be reviewed and refined to reduce
repetition, ensure appropriate grouping of outcome
domains, and review the mapping of outcome
domains to the WHO-ICF framework.
3. Producing meaningful outcome statements: we will
consider, and where necessary, revise outcome
statements for each outcome domain through
discussion to achieve a list of outcome domains
with meaningful statements.
The revised outcome domains list and meaningful
statements will be written in plain English, using both
open and closed-format questions, forming the basis for
an on-line e-Delphi questionnaire (stage 4). The ques-
tionnaire will be piloted with the core team, PPI part-
ners, and researchers naïve to the study (n = 10).
Stage four: Achieving outcome prioritisation and core
domain confirmation in an international, multi-
stakeholder e-Delphi study
Delphi studies utilise a process of sequential question-
naire completion and feedback to establish expert
consensus between a panel of experts [53]. To ensure
that the COSTA reflects the perspectives of experts in
the field of tibial and ankle fracture, two panels will be
defined: (1) patients who have experienced a distal tibia
or ankle fracture and (2) health professionals and re-
searchers who are active in this field, representative of
their professional groups, and well-positioned to imple-
ment the COSTA recommendations [54].
Consensus or accepted standards for sample sizes for
Delphi studies are currently lacking [53], with expert
panel sizes described in COS development ranging from
15 [55] to over 200 panellists [56]. We refer to recent
examples of Delphi studies where pre-identified expert
panels of between 60 and 70 panellists per panel are de-
scribed [57–59]. This will facilitate a wide expert view
and accommodate for attrition across rounds. Eligibility
criteria for panellists are presented in Table 3.
Expert panel 1: We will identify patients—adults aged
18 years and over who have sustained a fracture of the
distal tibia or ankle within the 2-year period of the start
of the e-Delphi—as per the recruitment approach speci-
fied in stage two. This will be a UK-based sample. A
‘pre-agreed’ list of participants will be established and in-
vited to participate in the e-Delphi.
Expert panel 2: A selected group of international
health professionals (clinicians / surgeons, physiothera-
pists, occupational therapists, nurses), and researchers
(trialists, reviewers, measurement experts) known to be
actively involved in delivering fracture care, or in frac-
ture research of relevance to distal tibia and ankle frac-
tures, will be identified through national and
international professional networks (e.g. AO Trauma
Network) and societies (e.g. the British Orthopaedic Foot
and Ankle Society, Association of Foot and Ankle Phys-
iotherapists), published research and involvement in
clinical trials. Recruitment approaches will be supple-
mented by snowballing and personal contacts. Potential
participants will be invited by e-mail to consider partici-
pation in the study. A pre-agreed list will be established
and invited to participate in the e-Delphi.
Modified e-Delphi method
The modified e-Delphi will be conducted using the
COMET DelphiManager software (University of Liver-
pool). It will consist of three sequential rounds with the
same group of panellists: participants completing round
1 will be eligible to complete round 2, and those com-
pleting round 2 will be eligible to complete round 3. Par-
ticipants will have up to 2-weeks to complete each
round, with reminders sent after 1 week and again 24 h
before the round is closed. Data will be analysed using
descriptive statistics and presented using measures of
central tendency, and as graphs, where necessary. Miss-
ing data will be examined across each outcome domain
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to identify potential patterns in non-response (e.g. by
panel, or other characteristics). If an item-level pattern is
observed (i.e. > 10% of responses are missing), we will
check this against qualitative feedback provided by
participants.
Round 1: Participants will be invited to rate the relative
importance of each outcome domain for ‘inclusion in fu-
ture distal tibia and ankle fracture research studies’ using
a nine-point numeric rating scale (range: 1–3 ‘not at all
important’, 4–6 ‘uncertain’ and 7–9 ‘very important’).
An additional option ‘unable to rate’ will also be pro-
vided. Participants can elaborate on their decisions, pro-
viding additional qualitative comments and feedback for
consideration in subsequent rounds. Evidence suggests
that attrition can be reduced with such active engage-
ment [53, 60].
A reduction in the number of outcome domains is a
key objective of the Delphi study, seeking to achieve
consensus on a minimum number of outcome domains
(core domain set) for the COS. Therefore, a bespoke
grading system, described in the development of a COS
for migraine (COSMIG), will be adopted to provide
greater clarity where participants from different sub-
groups either agree or disagree in their judgements [61].
This approach defines clear criteria and decision rules
for handling differing levels of consensus e.g. little or no
consensus (grade C or D), uncertainty (grade A and B),
and clear consensus (grade A** and A*) per outcome
domain. Only outcome domains judged most favourably
by one or both expert panels will be included in round
two (Table 4).
Round 2: Responses to round one will be summarised
(individual and group median scores for each outcome).
Qualitative feedback will inform the inclusion of add-
itional or edits to existing outcome domains.
Further prioritisation will be sought by inviting panel-
lists to allocate ‘points’ to illustrate how important they
feel an outcome domain is for inclusion in the core do-
main set. Each outcome domain will be assessed using
an 11-point numeric rating scale, where 0 is not a prior-
ity, and 10 an absolute priority. A maximum of 70 points
can be spent, with a maximum of 10 points can be
assigned to any one outcome domain.
The sums of priority ratings will be calculated (per
sub-panel and combined), supporting the identification
of both the top 10 and top 50% of prioritised outcome
domains. These will be discussed by the core research
team. Outcome domains will be retained as they are, or
if considered to be similar concepts of health, grouped
into a new higher order of ‘meaningful’ outcome do-
mains [61, 62].
Round 3: Participants will be asked to consider if they
are happy with a series of decisions informed by earlier
rounds. First, they will be advised of the top 50% of
prioritised outcome domains from round 2. They will
then be advised of any between-panel discrepancies.
Table 3 Eligibility criteria for participants in the e-Delphi
Inclusion criteria Exclusion criteria
Generic criteria
(all)
Aged 18 years or older Unable to access a computer or digital device for the duration of the
study
Willing to participate in a multi-round online Delphi
study
Proficient in written English
Expert panel 1
(patients)
Has experienced a fracture of the distal tibia/ankle within
the last 2 years (at the point of contact)
Fracture involved multiple sites defined as outside of the distal tibia
and ankle (AO criteria [31])
Expert panel 2
(professionals)
Has experience working, or conducting research, with
ankle fracture patients
Limited experience (less than 9 months) working in fracture care and
no experience of working with distal tibia and ankle fractures
Table 4 Grading system for determining consensus in round 1 of the e-Delphi study
Grade Criteria for judging agreement Decision rule
A** Median rating is 9 for both expert panels Include in round 2
A* ≥ 70% of respondents in each panel rate an outcome domain ≥
7
Include in round 2
A Median rating for an outcome domain is ≥ 7 for both expert
panels
Include in round 2 if one of the panels achieves a median score of 9 OR
qualitative evidence supports further consideration
B Median rating for an outcome domain is ≥ 7 for only one expert
panel
Include in round 2 if this group achieves a median score of 9 OR
qualitative evidence supports further consideration
C Median rating for the two panels combined is ≥ 4 and ≤ 6, and
the median rating for no single panel is ≥ 7
Exclude from round 2 (unless strong qualitative evidence supports further
consideration)
D Median rating for the two panels combined is ≥ 1 and ≤ 3, and
the median rating for no single group is ≥ 7
Exclude from round 2 (unless strong qualitative evidence supports further
consideration)
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Where outcome domains are prioritised by just one
panel, respondents will be asked to consider if they
should be included in the prioritised list (Yes/No); out-
come domains voted for inclusion by ≥70% of respon-
dents will be included. Finally, respondents will be asked
to specify if they agree (Yes/No) with the grouping of
prioritised outcome domains, and the meaningful out-
come domains and definitions. An option to provide
additional comments will be available. A frequency dis-
tribution of responses will be computed.
Achieving a core domain set
It is anticipated that a core domain set will be achieved
by the end of round 3. Whilst there is no agreed ‘ideal’
number of core domains, to be feasible and acceptable, a
smaller core domain set is recommended (i.e. fewer than
8 outcome domains) [63]. However, numerous examples
of COS development have required further consensus
activities to clarify and ratify findings from the Delphi
process [20, 27, 61]. Recent protocols to develop core
outcome sets have also outlined plans for consensus
meetings to ratify a core domain set [64, 65]. Should a
core domain set not be achieved following the e-Delphi,
then the findings will be taken to a consensus meeting
for final voting and ratification (stage 5) before seeking
consensus on a core measurement set.
Stage 5: Consensus meeting
The aim of this meeting will be to confirm the core do-
main set (stage 4), agree a core measurement set (CMS)
and recommend the COS for distal Tibia and Ankle
fracture (COSTA). Outcome domains that are consid-
ered important but do not have an available measure-
ment approach will not be included within the COS.
We will invite health professionals and patients who
participated in the e-Delphi study to take part in this
consensus meeting. In advance of the meeting, partici-
pants will be provided with an information pack outlin-
ing the objectives of the meeting—this will include the
CDS and short-listed outcome measures to be consid-
ered for the CMS.
Developing the core measurement set
In advance of the meeting, we will identify available
guidance or existing consensus on how best to measure
short-listed outcome domains. Where there is no exist-
ing consensus for potential outcome measures, the core
research team will review key evidence sources to deter-
mine measurement quality [66], acceptability, and
feasibility.
The meeting will begin with an overview of the e-
Delphi and the prioritised outcome domains, with ac-
companying information on the evidence underpinning
identified measures. Participants will be asked to
consider ‘placement’ of the outcome domains within the
final COS [61, 62]:
1. Core ‘inner’ circle: outcome domain is clear with an
acceptable, method of assessment.
2. Middle circle: whilst important, the inclusion of this
outcome domain in all trials is not feasible (e.g. lack
of available assessment method).
3. Outer circle: whilst important, the current available
evidence for the conceptualisation of the outcome
domain or assessment method is limited.
The meeting will be structured into three parts:
i. Initial presentations to the large group will be
followed by facilitated small-group discussions with
a mixed group of stakeholders. Groups will discuss
each prioritised outcome domain and potential
method of assessment, considering evidence of
quality, acceptability, feasibility, and importance.
Findings between groups will then be shared to fa-
cilitate further discussion.
ii. At the end of each small-group discussion, partici-
pants will anonymously complete a questionnaire to
confirm the inclusion of each outcome domain
(Yes/No/Don’t know) and their preferred method of
assessment (selecting from a short-list). Agreement
will be defined as ≥ 70% participants endorsing an
outcome domain and/or method of assessment.
iii. A whole group discussion will be facilitated to
discuss outcome domain priorities or assessment
methods. Where there is agreement, no further
discussion will be required. Subsequent discussions
will focus on areas of disagreement and where
further refinement is required. Finally, participants
will be asked to anonymously vote electronically to
confirm ‘placement’ of all core domains (inner,
middle or outer circles), and, where previously not
confirmed, the preferred method of assessment.
Written notes will be taken throughout the sessions,
and the voting will be recorded.
The outcome of this consensus meeting will be to rat-
ify a COS for distal tibia and ankle trials, identifying
both the core outcome domains that should be minim-
ally assessed, alongside evidence-based recommenda-
tions on current best methods for assessment.
Dissemination
In line with recommendations, ongoing work will be ne-
cessary to maximise the uptake and implementation of
the COS [16]. We will seek to actively address this chal-
lenge through our close active collaboration with our
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PPI group and engagement with our international advis-
ory group.
Participants in the research will be informed of project
outcomes through the sharing of a summary document
following completion of each stage. This will be shared
directly with participants via email. COS users (including
funders and journal editors) will be reached through a
range of methods, including wide dissemination through
publications and both national and international confer-
ence presentations. Additionally, AO Trauma’s inter-
national reach through their leading expertise in trauma
will enable the team to directly inform the international
trauma community about COSTA.
Discussion
Currently, outcome reporting guidance for distal tibia or
ankle fractures is lacking, despite the need for such guid-
ance being highlighted in recent reviews [9–11]. The de-
velopment and uptake of a core outcome set for tibia
and ankle fractures (COSTA) will ensure that outcomes
viewed as important to key stakeholders are included in
clinical trials, supporting the development of an evidence
base that can be synthesised and better examined to sup-
port healthcare decisions.
A limitation of the COS is that it will rely on a UK
sample of patients throughout. This is due to project
time constraints which are amplified by COVID. How-
ever, systematic reviews of international qualitative and
quantitative literature will be used to inform an initial
long list of potential outcome domains.
A well-developed COSTA will address the current
challenges associated with heterogeneity in outcome se-
lection and reporting in ankle fracture research [9–11]
through improving opportunities for evidence synthesis,
creating opportunity for comparative reviews of care
provision across different fracture types, reducing
reporting bias, and reducing research waste [13–15]. To
ensure these benefits are brought to fruition, ongoing
work will be necessary to ensure the uptake and imple-
mentation of COSTA. This will involve maximising dis-
semination of the COS and highlighting its value in
application for both clinical practice and research.
Trial status
Protocol version number: 1.0
Protocol date: March 8, 2021
Recruitment start date: delayed due to COVID
Planned recruitment end date: January 2022
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